NC
HALO icon

NewSquare Capital’s Halozyme HALO Stock Holding History

NewSquare Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35
Closed -$1.26K – 716
2023
Q2 		$1.26K Hold
35
– – ﹤0.01% 579
2023
Q1 		$1.34K Sell
35
-5
-13% -$235 ﹤0.01% 617
2022
Q4 		$2.28K Buy
+40
New +$2.05K ﹤0.01% 467
2019
Q4 		– Sell
-267
Closed -$4K – 312
2019
Q3 		$4K Hold
267
– – ﹤0.01% 234
2019
Q2 		$5K Buy
+267
New +$4.31K ﹤0.01% 288

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

NewSquare Capital's HALO Position: Q3 2023 in Review

NewSquare Capital sold out of Halozyme (HALO) in Q3 2023, closing a stake of 35 shares — an estimated $1.26K sold.

NewSquare Capital first reported a position in HALO in Q2 2019 and held it in 5 quarters. The position peaked at $5K in Q2 2019. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

  • NewSquare Capital reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
  • NewSquare Capital sold 35 Halozyme shares in Q3 2023, an estimated $1.26K.
  • NewSquare Capital first reported a position in Halozyme in Q2 2019 and held it in 5 quarters.
  • NewSquare Capital's Halozyme position peaked at $5K in Q2 2019.
  • 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.